Skip to main content
SpringerLink
Log in

Drug Product Development for Older Adults—Multiparticulate Formulations

  • Chapter
  • First Online:
Developing Drug Products in an Aging Society

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 26))

Abstract

The multiparticulate drug product concept covering micropellets, pellets, and mini-tablets is presented as a highly feasible approach to present convenient and patient friendly medication for the geriatric population. Improved swallowability and optimized administration regimen going along with defined drug dosage are achievable. Extemporaneous preparation of medicines from standard medication can be avoided going along with improved patient safety. With one multiparticulate pellet, micropellet, or mini-tablet bulk formulation a broad range of final drug products is presentable applying well-established manufacturing technologies at viable cost.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stegemann S, Ecker F, Maio M, Kraahs P, Wohlfahrt R, Breitkreutz J, Zimmer A, Bar-Shalom D, Hettrich P, Broegmann B. Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev. 2010;9:384–98.

    Article  PubMed  Google Scholar 

  2. ICH Harmonised Tripartite Guideline Pharmaceutical Development Q8(R2). 2009.

    Google Scholar 

  3. Stegemann S, Gosch M, Breitkreutz J. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int J Pharm. 2012;430:197–206.

    Article  CAS  PubMed  Google Scholar 

  4. Stegemann S, Rasenack N, Ecker F, Zimmer A. Geriatrische Arzneimitteltherapie – Gesellschaftliche Herausforderung und pharmazeutische Lösungsansätze. DAZ. 2011;31:44–61.

    Google Scholar 

  5. Bar-Shalom D. The challenge of automated compounding. In: Bar-Shalom D, Rose K, editors. AAPS Springer Verlag; 2014. p. 181–91.

    Google Scholar 

  6. Stegemann S. Maßgeschneiderte Arzneiformen. DAZ. 2014;46:60–5.

    Google Scholar 

  7. EMEA, Commission Guideline on the format and content of applications for agreement or modification of a paediatric investigation plan and requests for waivers or deferrals and concerning the operation of the compliance check and on criteria for assessing significant studies (2014/C 338/ 01). 2014.

    Google Scholar 

  8. Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opinion Drug Deliv. 2007;4(1):37–45.

    Article  CAS  Google Scholar 

  9. Timpe C, Dischinger A. Drug delivery strategies for oral pediatric and geriatric products. J Asia’s Pharm Biopharm Ind. 2014.

    Google Scholar 

  10. Kauzor D, Spielmann S, Brosig H, Ross R, Blankenstein O, Kloft C. Hydrocortisone in extemporaneously compounded capsules for paediatric use: a medication safety study. In: 6th conference of the EuPFI, Athens. 2014.

    Google Scholar 

  11. Ogilvie R. Industry perspective on formulation and packaging considerations; EFPIA. 2012.

    Google Scholar 

  12. Ranmal SR, Barker SA, Tuleu C. Paediatric solid formulations. . In: Bar-Shalom D, Rose K, editors. AAPS Springer Verlag; 2014. p. 153–70.

    Google Scholar 

  13. Biyyala V, Rumondor A, Thompson K, Harris D, Flanagan F, Burlage R, Smith RL. New modalities for solid dosage forms in pediatric populations—emphasis on minitablets. In: 7th conference of the EuPFI, Brussels. 2015.

    Google Scholar 

  14. World Health Organization (WHO) Annex 5: Development of paediatric medicines: points to consider in formulation. 2012.

    Google Scholar 

  15. Frey CR. Flavor is not just a taste: taste concealing. In: Bar-Shalom D, Rose K, editors. AAPS Springer Verlag; 2014. p. 123–39.

    Google Scholar 

  16. MØller P. Orosensory perception. In: Bar-Shalom D, Rose K, editors. AAPS Springer Verlag; 2014. p. 105–21.

    Google Scholar 

  17. Soto J. Assessing the aversive taste of medicines: a comparison between rat taste panels (via the BATA model) and human taste panels. In: 7th conference of the EuPFI, Brussels. 2015.

    Google Scholar 

  18. Guhmann M, Preis M, Gerber F, Pöllinger N, Breitkreutz J, Weitschies W. Development of oral taste masked diclofenac formulations using a taste sensing system. Int J Pharm. 2012;438:81–90.

    Article  CAS  PubMed  Google Scholar 

  19. Guhmann M, Preis M, Gerber F, Poellinger N, Breitkreutz J, Weitschies W. PBP World Meeting Lisbon. 2014.

    Google Scholar 

  20. Poellinger N. Microparticulates as drug carriers for pediatric use. In: 4th conference of the EuPFI, Prague. 2012.

    Google Scholar 

  21. Czajkowska M, Sznitowska M, Kotlowska H. Development of matrix type and coated prolonged release minitablets with carbamazepine. In: 7th conference of the EuPFI, Brussels. 2015.

    Google Scholar 

  22. Grave A, Steinebrunner M, Poellinger N. Development of highly drug loaded Metoprolol pellets using MicroPx technology. Istanbul: APV World Congress; 2012.

    Google Scholar 

  23. Pöllinger N, Michaelis J, Benke K, Rupp R, Bücheler M. US Patent 5,695,784. 1997.

    Google Scholar 

  24. Struschka M, Schwarz F, Luy B, Prasch A, Pöllinger N. EP 163 137 3 A1. 2006.

    Google Scholar 

  25. Grave A, Pöllinger N. In easy coating. In: Kumpgdee-Vollrath M, Krause JP, editors. Glatt Wirbelschichttechnologie zum Coating von Pulvern, Pellets und Mikropellets. Vieweg + Teubner Verlag; 2011. p. 80–119.

    Google Scholar 

  26. Grave A, Poellinger N, Whitaker M. Development of taste masked micropellets for paediatric use—scale up to production scale. In: 6th conference of the EuPFI, Athens. 2014.

    Google Scholar 

  27. Heppner HJ, Sieber CC, Esslinger AS, Trögner J. Arzneimittelformen und Arzneimittelverabreichung in der Geriatrie. Ther Umschau. 2006;63:419–22.

    Article  CAS  Google Scholar 

  28. Müller-Bohn T. Pädiatrie: Kinder: Stiefkinder der Arzneitherapie? 2007;DAZ 9: 63.

    Google Scholar 

  29. Grave A, Poellinger N, Whitaker M. Taste masked micropellets for pediatric use. 9th World Meeting on Pharmaceutics, Biopharmaceutics, Lisbon. 2014.

    Google Scholar 

  30. Poellinger N, Grave A. TAIN—a collaborative approach to meet patient needs in a rare disease. In: 6th conference of the EuPFI, Athens. 2014.

    Google Scholar 

  31. Capsugel, Coni-Snap Sprinkle Caps. 2015.

    Google Scholar 

  32. Lewis C, Segal J, McGovern J, Simmons J, Burley J. Mulitple unit orodispsible mini-tablets. In: 7th conference of the EuPFI, Brussels. 2015.

    Google Scholar 

  33. Bhad ME, Abdul S, Jaiswal SB, Chandewar AV, Jain JM, Sakarkar DM. MUPS tablets—a brief review. Int J Pharm Tech Res. 2010;2:847–55.

    CAS  Google Scholar 

  34. Pohl U., Führling C., Gieseler H. Neue Schmelztablette zur Migränetherapie. 2012;DAZ 14: 96.

    Google Scholar 

  35. Mostafa HF, Ibrahim MA, Sakr A. Dextromethorphan Hydrobromide orally disintegrating tablets. Pharm Ind. 2014;76:454–63.

    Google Scholar 

  36. Adam AK, Rauscher S, Zimmer C, Breitkreutz J. Multiple unit orodispersible mini-tablets. In: 7th conference of the EuPFI, Brussels. 2015.

    Google Scholar 

  37. Frey CR, Madsen JS. Liquid formulations. In: Bar-Shalom D, Rose K, editors. AAPS Springer Verlag; 2014.

    Google Scholar 

  38. Wan M, Hashimi AA, Batchelor H. Pharmacy and formulation support for clinical trials in England. In: 7th conference of the EuPFI, Brussels. 2015.

    Google Scholar 

  39. Raumedic AG, Dose Sipping Technology XStraw. 2014.

    Google Scholar 

  40. DS Technology. 2015.

    Google Scholar 

  41. Raumedic AG. 2015.

    Google Scholar 

  42. Wartenberg F. Vom Trockensaft zum Heilmittel –(k)ein Kinderspiel. 2007;DAZ 33: 36.

    Google Scholar 

  43. Arzneimittelapplikation per Sonde. 2006;DAZ 29:80.

    Google Scholar 

  44. Adare Pharmaceuticals; case study: use of minitablets technology to reliably and effectively deliver drugs through gastrostomy tube (G-tube). In: 7th conference of the EuPFI, Brussels. 2015.

    Google Scholar 

  45. Räth U, Kamann F. Medikamentenlehre für Altenpflegeberufe, 4. WVG Stuttgart: Aufl; 2015.

    Google Scholar 

  46. Schmidt V, Lipp H-P. Orale Liquida für die Pädiatrie – Entwicklung und Optimierung kindgerechter Zubereitungen DAZ. 2009;44:54.

    Google Scholar 

  47. Wenning K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches Int. J Pharm. 2011;404(1–2):1–9.

    Google Scholar 

  48. Stegemann S. Treatment of the elderly; APV course 6469, Prague. 2012.

    Google Scholar 

  49. Poellinger N.; Pediatric formulations in clinical testing and the challenge of final market formulation; pp 193–203 Ed. Bar-Shalom D., Rose K.; AAPS Springer Verlag (2014).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glatt GmbH, Pharmaceutical Services, Binzen, 79589, Germany

    Norbert Pöllinger

Authors
  1. Norbert Pöllinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norbert Pöllinger .

Editor information

Editors and Affiliations

  1. Graz University of Technology, Graz, Austria

    Sven Stegemann

Rights and permissions

Reprints and permissions

Copyright information

© 2016 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Pöllinger, N. (2016). Drug Product Development for Older Adults—Multiparticulate Formulations. In: Stegemann, S. (eds) Developing Drug Products in an Aging Society. AAPS Advances in the Pharmaceutical Sciences Series, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-43099-7_16

Download citation

Publish with us

Policies and ethics

Search

Navigation